KMID : 0931320170170030122
|
|
´ëÇÑ»óºÎÀ§Àå°ü.Ç︮ÄÚ¹ÚÅÍÇÐȸÁö 2017 Volume.17 No. 3 p.122 ~ p.126
|
|
Helicobacter pylori-negative Gastric Mucosa-associated Lymphoid Tissue Lymphoma
|
|
Jung Jin-Tae
|
|
Abstract
|
|
|
Approximately 90% of gastric mucosa-associated lymphoid tissue (MALT) lymphomas are associated with Helicobacter pylori infection and 10% of gastric MALT lymphomas occur independent of H. pylori infection. The gene translocation t(11;18)(q21;q21) is frequently observed in cases presenting with H. pylori-negative gastric MALT lymphomas. H. pylori-negative gastric MALT lymphomas do not differ from H. pylori-positive gastric MALT lymphomas in terms of clinical features and endoscopic findings and show similar prognosis. H. pylori eradication therapy could be considered as first-line treatment for gastric MALT lymphomas regardless of their H. pylori infection status. In cases with H. pylori-negative gastric MALT lymphomas, the rate of response to eradication therapy varies from 0 to 83%. If gastric MALT lymphoma persists for more than a year, secondary treatment with radiotherapy, chemotherapy, and/or surgery should be considered. Of note, the comparative outcome is excellent.
|
|
KEYWORD
|
|
Helicobacter pylori, Lymphoma, B-cell, marginal zone
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|